Lars Fruergaard Jørgensen, Novo Nordisk CEO (Christopher Goodney/Bloomberg via Getty Images)
Novo Nordisk sees growth slowing this year, plans CagriSema filing for 2026
Novo Nordisk had a good 2024, but this year might be less stellar.
The Danish company’s 2024 sales increased 26% from the year before at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
